RDUS - Radius Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.01B
Enterprise Value 31.02B
Trailing P/E N/A
Forward P/E 1-8.33
PEG Ratio (5 yr expected) 1-0.21
Price/Sales (ttm)8.78
Price/Book (mrq)35.83
Enterprise Value/Revenue 38.92
Enterprise Value/EBITDA 6-5.99

Trading Information

Stock Price History

Beta (3Y Monthly) 1.18
52-Week Change 3-19.08%
S&P500 52-Week Change 35.54%
52 Week High 328.84
52 Week Low 312.81
50-Day Moving Average 322.92
200-Day Moving Average 320.47

Share Statistics

Avg Vol (3 month) 3503.8k
Avg Vol (10 day) 3393.3k
Shares Outstanding 546.11M
Float 39.68M
% Held by Insiders 10.95%
% Held by Institutions 1109.13%
Shares Short (Jun 28, 2019) 47.02M
Short Ratio (Jun 28, 2019) 413.04
Short % of Float (Jun 28, 2019) 417.87%
Short % of Shares Outstanding (Jun 28, 2019) 415.22%
Shares Short (prior month May 31, 2019) 47.15M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Apr 24, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -176.84%
Operating Margin (ttm)-151.46%

Management Effectiveness

Return on Assets (ttm)-32.42%
Return on Equity (ttm)-181.50%

Income Statement

Revenue (ttm)114.54M
Revenue Per Share (ttm)2.52
Quarterly Revenue Growth (yoy)105.20%
Gross Profit (ttm)91.61M
EBITDA -170.65M
Net Income Avi to Common (ttm)-202.54M
Diluted EPS (ttm)-4.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)204.18M
Total Cash Per Share (mrq)4.43
Total Debt (mrq)191.28M
Total Debt/Equity (mrq)683.04
Current Ratio (mrq)5.16
Book Value Per Share (mrq)0.61

Cash Flow Statement

Operating Cash Flow (ttm)-168.96M
Levered Free Cash Flow (ttm)-92.45M